Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPK

MLA

Lee, Y-h, et al. “Exogenous Administration of DLK1 Ameliorates Hepatic Steatosis and Regulates Gluconeogenesis via Activation of AMPK.” International Journal of Obesity (Formerly International Journal of Obesity and Related Metabolic Disorders), vol. 40, no. 2, Feb. 2016, pp. 356–65. EBSCOhost, https://doi.org/10.1038/ijo.2015.173.

APA

Lee, Y., Yun, M. R., Kim, H. M., Jeon, B. H., Park, B.-C., Lee, B.-W., Kang, E. S., Lee, H. C., Park, Y. W., & Cha, B.-S. (2016). Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPK. International Journal of Obesity (Formerly International Journal of Obesity and Related Metabolic Disorders), 40(2), 356–365. https://doi.org/10.1038/ijo.2015.173

Chicago

Lee, Y-h, M R Yun, H M Kim, B H Jeon, B-C Park, B-W Lee, E S Kang, H C Lee, Y W Park, and B-S Cha. 2016. “Exogenous Administration of DLK1 Ameliorates Hepatic Steatosis and Regulates Gluconeogenesis via Activation of AMPK.” International Journal of Obesity (Formerly International Journal of Obesity and Related Metabolic Disorders) 40 (2): 356–65. doi:10.1038/ijo.2015.173.